Amadeus Integrates IBM Digital Health Pass Into Its Digital Health Verification Technology

IBMIBM (NYSE: IBM) and Amadeus (MCE: AMS) announced that they are working together to help meet one of the major challenges facing travel companies today: checking and validating the COVID-19 health documentation of travelers at checkpoints where required.

As part of that effort, IBM Digital Health Pass is now integrated into Traveler ID for Safe Travel, Amadeus' digital health verification solution. This enables airlines to integrate the use of COVID-19 digital health credentials into their existing reservation and booking system, allowing airline passengers the option to scan or upload documentation to show their health credentials.

As passengers move through the online check-in process, Traveler ID for Safe Travel checks the requirements for that particular trip against destination country regulations. This then prompts passengers with the option to generate a secure COVID-19 digital credential by scanning paper documents or uploading a digital version from their mobile or desktop.

These COVID-19 digital health credentials are then verified using IBM Digital Health Pass, which uses a combination of encryption and blockchain technologies to authenticate COVID-19 health credentials against a global ecosystem of labs, vaccination centers and healthcare providers. Airlines receive a simple status confirming a passenger is ready to fly. This secure approach provides passenger privacy since only the compliance with border entry requirements is confirmed; no personal health information is stored by the airline, IBM, or Amadeus.

"While countries across the globe are beginning to slowly reopen borders to welcome back visitors, specific border entry requirements may vary greatly country to country. The need to check COVID-19 health documentation is causing significant delays during the journey for airlines and other travel providers, as well as the traveler," said Greg Land, Travel and Transportation Industry Lead, IBM. "The integration of IBM Digital Health Pass into Amadeus' Traveler ID for Safe Travel is designed to provide airlines with open technologies they can build into existing digital solutions. This can help airlines safely meet border entry requirements while delivering a smoother customer experience."

"The integration with IBM is a step-change for Traveler ID for Safe Travel. The combination of the IBM Digital Health Pass with our Traveler ID for Safe Travel technology means that COVID-19 health documents can be digitized and read, verified, and authenticated. This avoids cumbersome and time-consuming checks while traveling, and adds further reassurance to airlines and their passengers," said Christian Warneck, VP Safe Travel Ecosystem, Amadeus. "This is another milestone in the collaboration we are driving through our Safe Travel Ecosystem. By working hand in hand with customers and partners such as IBM, we can deliver the capabilities needed by travel providers and travelers to help provide a smooth passenger journey once more."

Traveler ID for Safe Travel is currently live with multiple airlines, with additional airline customers to be announced soon. Traveler ID's digital identity and health verification capabilities are also relevant for other customer groups, including hotels and airports.

About IBM

For more information about IBM visit, www.ibm.com.

About Amadeus

Travel powers progress. Amadeus powers travel. Amadeus' solutions connect travelers to the journeys they want through travel agents, search engines, tour operators, airlines, airports, hotels, cars and railways. We have developed our technology in partnership with the travel industry for over 30 years. We combine a deep understanding of how people travel with the ability to design and deliver the most complex, trusted, critical systems our customers need. We help connect over 1.6 billion people a year to local travel providers in over 190 countries. We are one company, with a global mindset and a local presence wherever our customers need us. Our purpose is to shape the future of travel. We are passionate in our pursuit of better technology that makes better journeys.

Amadeus is an IBEX 35 company, listed on the Spanish Stock Exchange under AMS.MC. The company is also part of the EuroStoxx50 and has been recognized by the Dow Jones Sustainability Index for the last eight years.

To find out more about Amadeus, visit www.amadeus.com.

Most Popular Now

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...

Can AI Techniques Help Clinicians Assess…

Investigators have applied artificial intelligence (AI) techniques to gait analyses and medical records data to provide insights about individuals with leg fractures and aspects of their recovery. The study, published in...

AI Makes Retinal Imaging 100 Times Faste…

Researchers at the National Institutes of Health applied artificial intelligence (AI) to a technique that produces high-resolution images of cells in the eye. They report that with AI, imaging is...